China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Decline in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a significant decline in short interest in August. As of August 15th, there was short interest totalling 40,600 shares, a decline of 23.3% from the July 31st total of 52,900 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average daily volume of 513,500 shares, the short-interest ratio is presently 0.1 days.

China SXT Pharmaceuticals Stock Performance

SXTC traded down $0.06 during midday trading on Friday, reaching $0.63. The company had a trading volume of 257,257 shares, compared to its average volume of 759,310. The business has a 50-day moving average of $1.04 and a two-hundred day moving average of $1.30. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.51 and a current ratio of 1.60. China SXT Pharmaceuticals has a 1 year low of $0.60 and a 1 year high of $6.39.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.